Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062526 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
A Early Phase 1 study of Parkinson Disease and Healthy Volunteer, sponsored by University of Pennsylvania.
- Active
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04062526 is a Early Phase 1 study of Parkinson Disease and Healthy Volunteer that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 11 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04062526, a Early Phase 1 study of Parkinson Disease and Healthy Volunteer, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an imaging drug called 18F-NOS which will be used to measure inflammation in the brain.
Conditions Studied
Interventions
- DRUG [18F]NOS
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2026-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04062526
The ClinicalTrials.gov registry entry for NCT04062526 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which [18F]NOS is the first listed.
NCT04062526 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04062526 about?
NCT04062526 is a clinical study titled "Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT". The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an ...
What is the current status of trial NCT04062526?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2019-08-14. Estimated completion is 2026-04.
What conditions does trial NCT04062526 study?
This clinical trial studies the following conditions: Parkinson Disease, Healthy Volunteer.
What interventions are being tested in trial NCT04062526?
The interventions under investigation include: [18F]NOS (DRUG).
Who is sponsoring clinical trial NCT04062526?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04062526 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
RECRUITING · Early Phase 1
-
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
RECRUITING · Early Phase 1
-
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
RECRUITING · Early Phase 1
-
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
RECRUITING · Early Phase 1
-
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
RECRUITING · Early Phase 1
-
Quantitative Imaging of Brain Glymphatic Function in Humans
ACTIVE NOT RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.